Fortress Biotech, Inc. Quarterly Depreciation in USD from Q1 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Fortress Biotech, Inc. quarterly/annual Depreciation history and growth rate from Q1 2011 to Q3 2024.
  • Fortress Biotech, Inc. Depreciation for the quarter ending September 30, 2024 was $100K, a 75% decline year-over-year.
  • Fortress Biotech, Inc. Depreciation for the twelve months ending September 30, 2024 was $1.06M, a 62.2% decline year-over-year.
  • Fortress Biotech, Inc. annual Depreciation for 2023 was $2.23M, a 28.3% decline from 2022.
  • Fortress Biotech, Inc. annual Depreciation for 2022 was $3.11M, a 18.3% increase from 2021.
  • Fortress Biotech, Inc. annual Depreciation for 2021 was $2.63M, a 15.3% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $1.06M $100K -$300K -75% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $1.36M $400K -$400K -50% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $1.76M $377K -$467K -55.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.23M $186K -$584K -75.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $2.81M $400K -$400K -50% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $3.21M $800K $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $3.21M $844K +$105K +14.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $3.11M $770K +$45K +6.21% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $3.06M $800K +$100K +14.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $2.96M $800K +$200K +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $2.76M $739K +$136K +22.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.63M $725K +$172K +31.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $2.46M $700K +$100K +16.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $2.36M $600K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $2.36M $603K +$76K +14.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.28M $553K +$112K +25.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $2.17M $600K +$100K +20% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $2.07M $600K +$100K +20% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $1.97M $527K +$46K +9.56% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $1.92M $441K -$56K -11.3% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 $1.98M $500K +$100K +25% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1.88M $500K +$200K +66.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $1.68M $481K +$285K +145% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $1.39M $497K +$425K +590% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 $968K $400K +$200K +100% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $768K $300K +$120K +66.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $648K $196K -$78K -28.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 $726K $72K -$42K -36.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $768K $200K $0 0% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $768K $180K +$98K +120% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $670K $274K +$270K +6750% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $400K $114K +$105K +1167% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-16
Q3 2016 $295K $200K +$194K +3233% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $101K $82K +$77K +1540% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $24K $4K -$2K -33.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $26K $9K +$3K +50% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-16
Q3 2015 $23K $6K $0 0% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $23K $5K -$1K -16.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $24K $6K +$1K +20% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $23K $6K Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 $6K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $6K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 $5K +$2K +66.7% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q1 2013 $3K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-12
Q1 2011 $2K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.